These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3334938)

  • 1. Flow cytometric analysis of DNA and cell proliferation in ovarian tumors.
    Christov K; Vassilev N
    Cancer; 1988 Jan; 61(1):121-5. PubMed ID: 3334938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
    Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA flow cytometry of ovarian tumors with correlation to histopathology.
    Feichter GE; Kühn W; Czernobilsky B; Müller A; Heep J; Abel U; Haag D; Kaufmann M; Rummel HH; Kubli F
    Int J Gynecol Pathol; 1985; 4(4):336-45. PubMed ID: 3002995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
    Lage JM; Weinberg DS; Huettner PC; Mark SD
    Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of DNA content in human ovarian cancers.
    Erba E; Ubezio P; Pepe S; Vaghi M; Marsoni S; Torri W; Mangioni C; Landoni F; D'Incalci M
    Br J Cancer; 1989 Jul; 60(1):45-50. PubMed ID: 2803914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: clinical and biologic significance.
    Kimball RE; Schlaerth JB; Kute TE; Schlaerth AC; Santoso J; Ballon SC; Spirtos NM
    Am J Obstet Gynecol; 1997 Jun; 176(6):1319-26; discussion 1326-7. PubMed ID: 9215191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ploidy assessment of benign and malignant ovarian tumors by flow cytometry. A clinicopathologic study.
    Iversen OE; Skaarland E
    Cancer; 1987 Jul; 60(1):82-7. PubMed ID: 3581034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary.
    Brescia RJ; Barakat RA; Beller U; Frederickson G; Suhrland MJ; Dubin N; Demopoulos RI
    Cancer; 1990 Jan; 65(1):141-7. PubMed ID: 2293860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
    Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
    Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulosa cell tumor of ovary: a clinicopathologic and flow cytometric DNA analysis.
    Roush GR; el-Naggar AK; Abdul-Karim FW
    Gynecol Oncol; 1995 Mar; 56(3):430-4. PubMed ID: 7705680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of salivary gland tumors studied by flow cytometry.
    Tytor M; Gemryd P; Wingren S; Grenko RT; Lundgren J; Lundquist PG; Nordenskjöld B
    Head Neck; 1993; 15(6):514-21. PubMed ID: 8253558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric DNA ploidy analysis of ovarian granulosa cell tumors.
    Chadha S; Cornelisse CJ; Schaberg A
    Gynecol Oncol; 1990 Feb; 36(2):240-5. PubMed ID: 2298413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-parameter flow cytometric analysis coupling the measurements of forward-angle light scatter and DNA content of archival ovarian carcinomas of low malignant potential.
    Eriksen B; Miller DS; Murad TM; Lurain JR; Bauer KD
    Anal Quant Cytol Histol; 1991 Feb; 13(1):45-53. PubMed ID: 2025373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma.
    Volm M; Brüggemann A; Günther M; Kleine W; Pfleiderer A; Vogt-Schaden M
    Cancer Res; 1985 Oct; 45(10):5180-5. PubMed ID: 4027994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.
    Erba E; Vaghi M; Pepe S; Amato G; Bistolfi M; Ubezio P; Mangioni C; Landoni F; Morasca L
    Br J Cancer; 1985 Oct; 52(4):565-73. PubMed ID: 4063134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric DNA measurements in human thyroid tumors.
    Christov K
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(3):255-63. PubMed ID: 2874658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.